Agomab Therapeutics NV Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
LSP 7 Cooperatieve U.A. and LSP 7 Management B.V. have disclosed a 10.6% beneficial ownership in AgomAb Therapeutics NV following an IPO and additional share purchases.